Timing of surgery for chronic subdural hematoma in patients with mild to moderate symptoms: a retrospective cohort study

轻中度症状慢性硬膜下血肿患者手术时机的选择:一项回顾性队列研究

阅读:1

Abstract

BACKGROUND: Burr hole drainage is the mainstay of treatment for chronic subdural hematoma (cSDH). However, the impact of the interval between diagnosis and surgery on clinical outcome is unknown. This study investigates whether surgical timing affects outcome in patients with mild to moderate symptoms who do not require immediate surgery. METHODS: We performed a single center, retrospective cohort study of 330 surgically treated cSDH patients with a Markwalder Grading Scale score of 1-2, at the Amsterdam UMC, between 2012 and 2022. The interval between diagnosis and surgery was measured in hours and dichotomized (surgery within vs. after 24 h). To account for potential confounding by hematoma mass effect, patients were stratified based on midline shift (greater than 10 mm vs < 10 mm). Primary outcomes included reoperation rate, complication rate, 30-day mortality, length of hospital stay and discharge destination. Univariable and multivariable regression analyses were performed for each stratum. RESULTS: The mean age of the cohort was 73 years, and 241 (73%) were male. The median time to surgery was 25 h (IQR 15-54). Among the 330 patients, 157 (48%) underwent surgery within 24 h after diagnosis. Patients who received early surgery (< 24 h) had a significantly higher proportion of midline shift > 10 mm compared to those undergoing later surgery (56% vs. 34%, p < 0.001). The use of anticoagulant or antiplatelet therapy did not differ between groups (47% vs 54%, p = 0.27). No significant association was found between surgical timing and any primary outcome across all strata. CONCLUSION: In patients with cSDH presenting with mild to moderately symptoms, the timing of surgery did not affect clinical outcome, particularly as delayed surgery did not result in poorer outcomes. These findings suggest that postponing surgery to daytime hours may be safe in this subgroup. Validation in prospective studies, ideally incorporating functional outcomes, is nevertheless required to confirm these results and guide clinical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。